Original Source: www.klusster.com/portfolios/acidrefluxmd/contents/22914
Gastroesophageal reflux disease (GERD) is one of the diseases found and managed most frequently in the primary care setting. One of the most common gastrointestinal disorders managed by gastroenterologists and primary care physicians are the gastroesophageal reflux disease (GERD) characterized by heartburn or regurgitation symptoms. The prevalence of GERD has increased especially in some nations. However, there has recently been a growing awareness among doctors and patients of the side effects of the PPI class of drugs.
Additionally, there was a marked decline in the use of surgical fundoplication as well as an increase in the development of non-medical therapeutic modalities for GERD. This review focuses on various GERD management strategies, optimal GERD refractory management with a special focus on available endoluminal therapies and future directions. Gastroesophageal reflux disease (GERD) assigns or complications arising from gastric reflux into or outside the oesophagus, or into the oral cavity or lung. The three phenotypical manifestations of GERD are erosive esophagitis (EE), nonerosive reflux disease (NERD), and Barrett's oesophagus.
Throughout general, patients with very little progression or regression appear to stay within their phenotypic appearance throughout their lifespan. For certain countries, GERD is a common condition with the highest prevalence. Heartburn and regurgitation are the main signs of GERD. GERD may, however, present with several other symptoms, including water brash, chest pain or discomfort, dysphasia, belching, epigastric pain, nausea, and bloating. Patients may also experience extraesophageal symptoms such as cough, heaviness, throat clearing, throat or burning pain, wheezing and sleep disturbances.
Here are 5 Trends in Management of Gastroesophageal Reflux Disease:
Medical Therapy: Medical therapy is usually given or used in patients who tend to experience problematic GERD-related symptoms following lifestyle modifications. Medical treatment includes Gaviscon, antacids, histamine 2 receptor antagonists (H2RAs), PPIs, Carafate, TLESR reducer, and prokinetics. Thanks to its intense and persistent suppression of acid, PPIs are considered the most effective prescription treatment for GERD. PPIs are the most widely prescribed drug for both EE and NERD, but longitudinal studies have shown that NERD patients respond less well to PPIs than EE patients do.
Optimisation PPI Therapy: The first step in treating refractory GERD is PPI treatment optimisation. Improving compliance with PPI treatment is, therefore, an essential initial step towards improving treatment with PPI. To achieve full benefit, the prescribing providers should inform their patients about the value of taking the PPI regularly. New research found that compliance with a PPI was the highest when a gastroenterologist administered the drug and the lowest when patients received their PPI over the counter. Adhering to correct timing of PPI consumption is also an important step in maximizing PPI.
Refractory Heartburn: It is characterized as symptoms of gastric reflux not reacting to a double dose of a PPI. Successful refractory heartburn treatment relies on the process that underlies it. Depicts the recovery method and the different therapeutic strategies in heartburn patients who have failed treatment with PPI. Recent studies have shown that most patients suffering from refractory heartburn or other common GERD symptoms still lack GERD as the underlying cause. The frequently involved mechanisms include the physiological hypersensitivity to heartburn and reflux.
Side effects PPIs: However, PPIs have long been considered a safe class of medications, with a rush of publications over the last decade documenting several side effects due to long-term treatment such as dietary shortages, increased risk of gastroenteritis, traveller diarrheal, Clostridium difficile colitis, osteoporosis, and bone fracture, microscopic colitis, ischemic heart disease, chronic kidney injury, and dementia. Recent evidence demonstrated an increased incidence of chronic kidney failure in patients receiving PPIs, due to acute interstitial nephritis.
GERD Surgical Therapy: There are currently several surgical methods available for treating GERD. However, a recent study has shown a significant decline in the rate of surgical fundoplication use. Patients who are candidates for antireflux surgery should undergo pre-operative pH testing if they have regular endoscopy and no previous history of pH testing. Additionally, before surgery, all patients will undergo a high-resolution oesophageal manometry to rule out achalasia or other motor oesophageal disorders, such as absent contractility.
Here is every needed information regarding the management of Gastroesophageal Reflux Disease, it’s a way of use along with the side effects that can help one to understand the seriousness of the disease. This type of information makes customers rely on the services provided by us. Besides this, customers who wanted to collect more deep understanding regarding such issues and their solution along with the symptoms can interact with Refluxmd.com
If there is any query regarding Gastroesophageal Reflux Disease, feel free to contact us.